<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1990-11-01" modified="2020-10-07" version="204">
<accession>P17861</accession>
<accession>Q8WYK6</accession>
<accession>Q969P1</accession>
<accession>Q96BD7</accession>
<name>XBP1_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="34 38">X-box-binding protein 1</fullName>
<shortName evidence="34">XBP-1</shortName>
</recommendedName>
<alternativeName>
<fullName evidence="33">Tax-responsive element-binding protein 5</fullName>
<shortName evidence="33">TREB-5</shortName>
</alternativeName>
<component>
<recommendedName>
<fullName evidence="35">X-box-binding protein 1, cytoplasmic form</fullName>
</recommendedName>
</component>
<component>
<recommendedName>
<fullName evidence="35">X-box-binding protein 1, luminal form</fullName>
</recommendedName>
</component>
</protein>
<gene>
<name type="primary" evidence="38">XBP1</name>
<name type="synonym" evidence="33">TREB5</name>
<name type="synonym" evidence="38">XBP2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1990" name="Science" volume="247" first="1581" last="1584">
<title>A new member of the leucine zipper class of proteins that binds to the HLA DR alpha promoter.</title>
<authorList>
<person name="Liou H.-C."/>
<person name="Boothby M.R."/>
<person name="Finn P.W."/>
<person name="Davidon R."/>
<person name="Nabavi N."/>
<person name="Zeleznik-Le N.J."/>
<person name="Ting J.P.-Y."/>
<person name="Glimcher L.H."/>
</authorList>
<dbReference type="PubMed" id="2321018"/>
<dbReference type="DOI" id="10.1126/science.2321018"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION (ISOFORM 1)</scope>
<scope>DNA-BINDING (ISOFORM 1)</scope>
<source>
<tissue>B-cell</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1990" name="EMBO J." volume="9" first="2537" last="2542">
<title>Multiple cDNA clones encoding nuclear proteins that bind to the tax-dependent enhancer of HTLV-1: all contain a leucine zipper structure and basic amino acid domain.</title>
<authorList>
<person name="Yoshimura T."/>
<person name="Fujisawa J."/>
<person name="Yoshida M."/>
</authorList>
<dbReference type="PubMed" id="2196176"/>
<dbReference type="DOI" id="10.1002/j.1460-2075.1990.tb07434.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION (ISOFORM 1)</scope>
<scope>DNA-BINDING (ISOFORM 1)</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1993" name="J. Biol. Chem." volume="268" first="17074" last="17082">
<title>The regulatory gene, hXBP-1, and its target, HLA-DRA, utilize both common and distinct regulatory elements and protein complexes.</title>
<authorList>
<person name="Ponath P.D."/>
<person name="Fass D."/>
<person name="Liou H.C."/>
<person name="Glimcher L.H."/>
<person name="Strominger J.L."/>
</authorList>
<dbReference type="PubMed" id="8349596"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>FUNCTION</scope>
<scope>DNA-BINDING</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2001" name="Cell" volume="107" first="881" last="891">
<title>XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor.</title>
<authorList>
<person name="Yoshida H."/>
<person name="Matsui T."/>
<person name="Yamamoto A."/>
<person name="Okada T."/>
<person name="Mori K."/>
</authorList>
<dbReference type="PubMed" id="11779464"/>
<dbReference type="DOI" id="10.1016/s0092-8674(01)00611-0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2)</scope>
<scope>FUNCTION (ISOFORM 2)</scope>
<scope>ALTERNATIVE SPLICING (ISOFORM 2)</scope>
<scope>DNA-BINDING (ISOFORMS 1 AND 2)</scope>
<scope>INDUCTION (ISOFORM 2)</scope>
<scope>ER STRESS-MEDIATED DOWN-REGULATION (ISOFORM 1)</scope>
<scope>DOMAIN ((ISOFORMS 1 AND 2)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Biol." volume="5" first="R84.1" last="R84.11">
<title>A genome annotation-driven approach to cloning the human ORFeome.</title>
<authorList>
<person name="Collins J.E."/>
<person name="Wright C.L."/>
<person name="Edwards C.A."/>
<person name="Davis M.P."/>
<person name="Grinham J.A."/>
<person name="Cole C.G."/>
<person name="Goward M.E."/>
<person name="Aguado B."/>
<person name="Mallya M."/>
<person name="Mokrab Y."/>
<person name="Huckle E.J."/>
<person name="Beare D.M."/>
<person name="Dunham I."/>
</authorList>
<dbReference type="PubMed" id="15461802"/>
<dbReference type="DOI" id="10.1186/gb-2004-5-10-r84"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1999" name="Nature" volume="402" first="489" last="495">
<title>The DNA sequence of human chromosome 22.</title>
<authorList>
<person name="Dunham I."/>
<person name="Hunt A.R."/>
<person name="Collins J.E."/>
<person name="Bruskiewich R."/>
<person name="Beare D.M."/>
<person name="Clamp M."/>
<person name="Smink L.J."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Babbage A.K."/>
<person name="Bagguley C."/>
<person name="Bailey J."/>
<person name="Barlow K.F."/>
<person name="Bates K.N."/>
<person name="Beasley O.P."/>
<person name="Bird C.P."/>
<person name="Blakey S.E."/>
<person name="Bridgeman A.M."/>
<person name="Buck D."/>
<person name="Burgess J."/>
<person name="Burrill W.D."/>
<person name="Burton J."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chen Y."/>
<person name="Clark G."/>
<person name="Clegg S.M."/>
<person name="Cobley V.E."/>
<person name="Cole C.G."/>
<person name="Collier R.E."/>
<person name="Connor R."/>
<person name="Conroy D."/>
<person name="Corby N.R."/>
<person name="Coville G.J."/>
<person name="Cox A.V."/>
<person name="Davis J."/>
<person name="Dawson E."/>
<person name="Dhami P.D."/>
<person name="Dockree C."/>
<person name="Dodsworth S.J."/>
<person name="Durbin R.M."/>
<person name="Ellington A.G."/>
<person name="Evans K.L."/>
<person name="Fey J.M."/>
<person name="Fleming K."/>
<person name="French L."/>
<person name="Garner A.A."/>
<person name="Gilbert J.G.R."/>
<person name="Goward M.E."/>
<person name="Grafham D.V."/>
<person name="Griffiths M.N.D."/>
<person name="Hall C."/>
<person name="Hall R.E."/>
<person name="Hall-Tamlyn G."/>
<person name="Heathcott R.W."/>
<person name="Ho S."/>
<person name="Holmes S."/>
<person name="Hunt S.E."/>
<person name="Jones M.C."/>
<person name="Kershaw J."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Laird G.K."/>
<person name="Langford C.F."/>
<person name="Leversha M.A."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Martyn I.D."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L.H."/>
<person name="Mccann O.T."/>
<person name="Mcclay J."/>
<person name="Mclaren S."/>
<person name="McMurray A.A."/>
<person name="Milne S.A."/>
<person name="Mortimore B.J."/>
<person name="Odell C.N."/>
<person name="Pavitt R."/>
<person name="Pearce A.V."/>
<person name="Pearson D."/>
<person name="Phillimore B.J.C.T."/>
<person name="Phillips S.H."/>
<person name="Plumb R.W."/>
<person name="Ramsay H."/>
<person name="Ramsey Y."/>
<person name="Rogers L."/>
<person name="Ross M.T."/>
<person name="Scott C.E."/>
<person name="Sehra H.K."/>
<person name="Skuce C.D."/>
<person name="Smalley S."/>
<person name="Smith M.L."/>
<person name="Soderlund C."/>
<person name="Spragon L."/>
<person name="Steward C.A."/>
<person name="Sulston J.E."/>
<person name="Swann R.M."/>
<person name="Vaudin M."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="Whiteley M.N."/>
<person name="Willey D.L."/>
<person name="Williams L."/>
<person name="Williams S.A."/>
<person name="Williamson H."/>
<person name="Wilmer T.E."/>
<person name="Wilming L."/>
<person name="Wright C.L."/>
<person name="Hubbard T."/>
<person name="Bentley D.R."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Shimizu N."/>
<person name="Minoshima S."/>
<person name="Kawasaki K."/>
<person name="Sasaki T."/>
<person name="Asakawa S."/>
<person name="Kudoh J."/>
<person name="Shintani A."/>
<person name="Shibuya K."/>
<person name="Yoshizaki Y."/>
<person name="Aoki N."/>
<person name="Mitsuyama S."/>
<person name="Roe B.A."/>
<person name="Chen F."/>
<person name="Chu L."/>
<person name="Crabtree J."/>
<person name="Deschamps S."/>
<person name="Do A."/>
<person name="Do T."/>
<person name="Dorman A."/>
<person name="Fang F."/>
<person name="Fu Y."/>
<person name="Hu P."/>
<person name="Hua A."/>
<person name="Kenton S."/>
<person name="Lai H."/>
<person name="Lao H.I."/>
<person name="Lewis J."/>
<person name="Lewis S."/>
<person name="Lin S.-P."/>
<person name="Loh P."/>
<person name="Malaj E."/>
<person name="Nguyen T."/>
<person name="Pan H."/>
<person name="Phan S."/>
<person name="Qi S."/>
<person name="Qian Y."/>
<person name="Ray L."/>
<person name="Ren Q."/>
<person name="Shaull S."/>
<person name="Sloan D."/>
<person name="Song L."/>
<person name="Wang Q."/>
<person name="Wang Y."/>
<person name="Wang Z."/>
<person name="White J."/>
<person name="Willingham D."/>
<person name="Wu H."/>
<person name="Yao Z."/>
<person name="Zhan M."/>
<person name="Zhang G."/>
<person name="Chissoe S."/>
<person name="Murray J."/>
<person name="Miller N."/>
<person name="Minx P."/>
<person name="Fulton R."/>
<person name="Johnson D."/>
<person name="Bemis G."/>
<person name="Bentley D."/>
<person name="Bradshaw H."/>
<person name="Bourne S."/>
<person name="Cordes M."/>
<person name="Du Z."/>
<person name="Fulton L."/>
<person name="Goela D."/>
<person name="Graves T."/>
<person name="Hawkins J."/>
<person name="Hinds K."/>
<person name="Kemp K."/>
<person name="Latreille P."/>
<person name="Layman D."/>
<person name="Ozersky P."/>
<person name="Rohlfing T."/>
<person name="Scheet P."/>
<person name="Walker C."/>
<person name="Wamsley A."/>
<person name="Wohldmann P."/>
<person name="Pepin K."/>
<person name="Nelson J."/>
<person name="Korf I."/>
<person name="Bedell J.A."/>
<person name="Hillier L.W."/>
<person name="Mardis E."/>
<person name="Waterston R."/>
<person name="Wilson R."/>
<person name="Emanuel B.S."/>
<person name="Shaikh T."/>
<person name="Kurahashi H."/>
<person name="Saitta S."/>
<person name="Budarf M.L."/>
<person name="McDermid H.E."/>
<person name="Johnson A."/>
<person name="Wong A.C.C."/>
<person name="Morrow B.E."/>
<person name="Edelmann L."/>
<person name="Kim U.J."/>
<person name="Shizuya H."/>
<person name="Simon M.I."/>
<person name="Dumanski J.P."/>
<person name="Peyrard M."/>
<person name="Kedra D."/>
<person name="Seroussi E."/>
<person name="Fransson I."/>
<person name="Tapia I."/>
<person name="Bruder C.E."/>
<person name="O'Brien K.P."/>
<person name="Wilkinson P."/>
<person name="Bodenteich A."/>
<person name="Hartman K."/>
<person name="Hu X."/>
<person name="Khan A.S."/>
<person name="Lane L."/>
<person name="Tilahun Y."/>
<person name="Wright H."/>
</authorList>
<dbReference type="PubMed" id="10591208"/>
<dbReference type="DOI" id="10.1038/990031"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Ovary</tissue>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1991" name="Proc. Natl. Acad. Sci. U.S.A." volume="88" first="4309" last="4312">
<title>Human X-box-binding protein 1 is required for the transcription of a subset of human class II major histocompatibility genes and forms a heterodimer with c-fos.</title>
<authorList>
<person name="Ono S.J."/>
<person name="Liou H.C."/>
<person name="Davidon R."/>
<person name="Strominger J.L."/>
<person name="Glimcher L.H."/>
</authorList>
<dbReference type="PubMed" id="1903538"/>
<dbReference type="DOI" id="10.1073/pnas.88.10.4309"/>
</citation>
<scope>FUNCTION (ISOFORM 1)</scope>
<scope>DNA-BINDING (ISOFORM 1)</scope>
<scope>INTERACTION WITH FOS (ISOFORM 1)</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1996" name="J. Exp. Med." volume="183" first="393" last="401">
<title>Transcription factor B cell lineage-specific activator protein regulates the gene for human X-box binding protein 1.</title>
<authorList>
<person name="Reimold A.M."/>
<person name="Ponath P.D."/>
<person name="Li Y.S."/>
<person name="Hardy R.R."/>
<person name="David C.S."/>
<person name="Strominger J.L."/>
<person name="Glimcher L.H."/>
</authorList>
<dbReference type="PubMed" id="8627152"/>
<dbReference type="DOI" id="10.1084/jem.183.2.393"/>
</citation>
<scope>INDUCTION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1996" name="Nucleic Acids Res." volume="24" first="1855" last="1864">
<title>The basic domain/leucine zipper protein hXBP-1 preferentially binds to and transactivates CRE-like sequences containing an ACGT core.</title>
<authorList>
<person name="Clauss I.M."/>
<person name="Chu M."/>
<person name="Zhao J.-L."/>
<person name="Glimcher L.H."/>
</authorList>
<dbReference type="PubMed" id="8657566"/>
<dbReference type="DOI" id="10.1093/nar/24.10.1855"/>
</citation>
<scope>FUNCTION (ISOFORM 1)</scope>
<scope>DNA-BINDING (ISOFORM 1)</scope>
<scope>DOMAIN (ISOFORMS 1 AND 2)</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1999" name="Int. J. Oncol." volume="15" first="173" last="178">
<title>Identification of c-myc promoter-binding protein and X-box binding protein 1 as interleukin-6 target genes in human multiple myeloma cells.</title>
<authorList>
<person name="Wen X.Y."/>
<person name="Stewart A.K."/>
<person name="Sooknanan R.R."/>
<person name="Henderson G."/>
<person name="Hawley T.S."/>
<person name="Reimold A.M."/>
<person name="Glimcher L.H."/>
<person name="Baumann H."/>
<person name="Malek L.T."/>
<person name="Hawley R.G."/>
</authorList>
<dbReference type="PubMed" id="10375612"/>
<dbReference type="DOI" id="10.3892/ijo.15.1.173"/>
</citation>
<scope>INDUCTION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2001" name="Nature" volume="412" first="300" last="307">
<title>Plasma cell differentiation requires the transcription factor XBP-1.</title>
<authorList>
<person name="Reimold A.M."/>
<person name="Iwakoshi N.N."/>
<person name="Manis J."/>
<person name="Vallabhajosyula P."/>
<person name="Szomolanyi-Tsuda E."/>
<person name="Gravallese E.M."/>
<person name="Friend D."/>
<person name="Grusby M.J."/>
<person name="Alt F."/>
<person name="Glimcher L.H."/>
</authorList>
<dbReference type="PubMed" id="11460154"/>
<dbReference type="DOI" id="10.1038/35085509"/>
</citation>
<scope>FUNCTION</scope>
<scope>INDUCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2003" name="Nat. Genet." volume="35" first="171" last="175">
<title>Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder.</title>
<authorList>
<person name="Kakiuchi C."/>
<person name="Iwamoto K."/>
<person name="Ishiwata M."/>
<person name="Bundo M."/>
<person name="Kasahara T."/>
<person name="Kusumi I."/>
<person name="Tsujita T."/>
<person name="Okazaki Y."/>
<person name="Nanko S."/>
<person name="Kunugi H."/>
<person name="Sasaki T."/>
<person name="Kato T."/>
</authorList>
<dbReference type="PubMed" id="12949534"/>
<dbReference type="DOI" id="10.1038/ng1235"/>
</citation>
<scope>INVOLVEMENT IN SUSCEPTIBILITY TO MAJOR AFFECTIVE DISORDER TYPE 7</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2004" name="J. Cell Biol." volume="167" first="35" last="41">
<title>XBP1: a link between the unfolded protein response, lipid biosynthesis, and biogenesis of the endoplasmic reticulum.</title>
<authorList>
<person name="Sriburi R."/>
<person name="Jackowski S."/>
<person name="Mori K."/>
<person name="Brewer J.W."/>
</authorList>
<dbReference type="PubMed" id="15466483"/>
<dbReference type="DOI" id="10.1083/jcb.200406136"/>
</citation>
<scope>FUNCTION (ISOFORM 2)</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2006" name="Cell Struct. Funct." volume="31" first="117" last="125">
<title>XBP1 is critical to protect cells from endoplasmic reticulum stress: evidence from Site-2 protease-deficient Chinese hamster ovary cells.</title>
<authorList>
<person name="Yoshida H."/>
<person name="Nadanaka S."/>
<person name="Sato R."/>
<person name="Mori K."/>
</authorList>
<dbReference type="PubMed" id="17110785"/>
<dbReference type="DOI" id="10.1247/csf.06016"/>
</citation>
<scope>INDUCTION (ISOFORM 2)</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2006" name="J. Cell Biol." volume="172" first="565" last="575">
<title>pXBP1(U) encoded in XBP1 pre-mRNA negatively regulates unfolded protein response activator pXBP1(S) in mammalian ER stress response.</title>
<authorList>
<person name="Yoshida H."/>
<person name="Oku M."/>
<person name="Suzuki M."/>
<person name="Mori K."/>
</authorList>
<dbReference type="PubMed" id="16461360"/>
<dbReference type="DOI" id="10.1083/jcb.200508145"/>
</citation>
<scope>FUNCTION (ISOFORMS 1 AND 2)</scope>
<scope>INTERACTION WITH XBP1 ISOFORM 2 (ISOFORM 1)</scope>
<scope>SUBCELLULAR LOCATION (ISOFORMS 1 AND 2)</scope>
<scope>INDUCTION (ISOFORMS 1 AND 2)</scope>
<scope>STRESS-MEDIATED DOWN-REGULATION (ISOFORM 1)</scope>
<scope>DOMAIN (ISOFORMS 1 AND 2)</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2007" name="Dev. Cell" volume="13" first="365" last="376">
<title>Transcriptional induction of mammalian ER quality control proteins is mediated by single or combined action of ATF6alpha and XBP1.</title>
<authorList>
<person name="Yamamoto K."/>
<person name="Sato T."/>
<person name="Matsui T."/>
<person name="Sato M."/>
<person name="Okada T."/>
<person name="Yoshida H."/>
<person name="Harada A."/>
<person name="Mori K."/>
</authorList>
<dbReference type="PubMed" id="17765680"/>
<dbReference type="DOI" id="10.1016/j.devcel.2007.07.018"/>
</citation>
<scope>INTERACTION WITH ATF6 (ISOFORM 2)</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2009" name="J. Cell Sci." volume="122" first="2877" last="2886">
<title>Unconventional splicing of XBP1 mRNA occurs in the cytoplasm during the mammalian unfolded protein response.</title>
<authorList>
<person name="Uemura A."/>
<person name="Oku M."/>
<person name="Mori K."/>
<person name="Yoshida H."/>
</authorList>
<dbReference type="PubMed" id="19622636"/>
<dbReference type="DOI" id="10.1242/jcs.040584"/>
</citation>
<scope>UNCONVENTIONAL ALTERNATIVE SPLICING (ISOFORM 2)</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2009" name="Mol. Cell" volume="34" first="191" last="200">
<title>Cotranslational targeting of XBP1 protein to the membrane promotes cytoplasmic splicing of its own mRNA.</title>
<authorList>
<person name="Yanagitani K."/>
<person name="Imagawa Y."/>
<person name="Iwawaki T."/>
<person name="Hosoda A."/>
<person name="Saito M."/>
<person name="Kimata Y."/>
<person name="Kohno K."/>
</authorList>
<dbReference type="PubMed" id="19394296"/>
<dbReference type="DOI" id="10.1016/j.molcel.2009.02.033"/>
</citation>
<scope>FUNCTION (ISOFORM 1)</scope>
<scope>SUBCELLULAR LOCATION (ISOFORMS 1 AND 2)</scope>
<scope>TOPOLOGY (ISOFORM 1)</scope>
<scope>DOMAIN (ISOFORM 1)</scope>
<scope>MUTAGENESIS OF TRP-189; VAL-193; LEU-194; LEU-196; ILE-198 AND TRP-205</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2009" name="Proc. Natl. Acad. Sci. U.S.A." volume="106" first="8326" last="8331">
<title>Sustained activation of XBP1 splicing leads to endothelial apoptosis and atherosclerosis development in response to disturbed flow.</title>
<authorList>
<person name="Zeng L."/>
<person name="Zampetaki A."/>
<person name="Margariti A."/>
<person name="Pepe A.E."/>
<person name="Alam S."/>
<person name="Martin D."/>
<person name="Xiao Q."/>
<person name="Wang W."/>
<person name="Jin Z.G."/>
<person name="Cockerill G."/>
<person name="Mori K."/>
<person name="Li Y.S."/>
<person name="Hu Y."/>
<person name="Chien S."/>
<person name="Xu Q."/>
</authorList>
<dbReference type="PubMed" id="19416856"/>
<dbReference type="DOI" id="10.1073/pnas.0903197106"/>
</citation>
<scope>FUNCTION (ISOFORM 2)</scope>
<scope>DNA-BINDING (ISOFORMS 1 AND 2)</scope>
<scope>INDUCTION (ISOFORMS 1 AND 2)</scope>
<scope>TISSUE SPECIFICITY (ISOFORMS 1 AND 2)</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2010" name="Nat. Med." volume="16" first="438" last="445">
<title>A regulatory subunit of phosphoinositide 3-kinase increases the nuclear accumulation of X-box-binding protein-1 to modulate the unfolded protein response.</title>
<authorList>
<person name="Winnay J.N."/>
<person name="Boucher J."/>
<person name="Mori M.A."/>
<person name="Ueki K."/>
<person name="Kahn C.R."/>
</authorList>
<dbReference type="PubMed" id="20348923"/>
<dbReference type="DOI" id="10.1038/nm.2121"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PIK3R1 (ISOFORM 2)</scope>
<scope>SUBCELLULAR LOCATION (ISOFORMS 1 AND 2)</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2011" name="Biochem. J." volume="433" first="245" last="252">
<title>Regulation of unfolded protein response modulator XBP1s by acetylation and deacetylation.</title>
<authorList>
<person name="Wang F.M."/>
<person name="Chen Y.J."/>
<person name="Ouyang H.J."/>
</authorList>
<dbReference type="PubMed" id="20955178"/>
<dbReference type="DOI" id="10.1042/bj20101293"/>
</citation>
<scope>ACETYLATION BY EP300 (ISOFORM 2)</scope>
<scope>DEACETYLATION BY SIRT1 (ISOFORM 2)</scope>
<scope>SUBCELLULAR LOCATION (ISOFORM 2)</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2011" name="Science" volume="331" first="586" last="589">
<title>Translational pausing ensures membrane targeting and cytoplasmic splicing of XBP1u mRNA.</title>
<authorList>
<person name="Yanagitani K."/>
<person name="Kimata Y."/>
<person name="Kadokura H."/>
<person name="Kohno K."/>
</authorList>
<dbReference type="PubMed" id="21233347"/>
<dbReference type="DOI" id="10.1126/science.1197142"/>
</citation>
<scope>FUNCTION (ISOFORM 1)</scope>
<scope>DOMAIN (ISOFORM 1)</scope>
<scope>MUTAGENESIS OF LEU-246; SER-255 AND TRP-256</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2013" name="Circulation" volume="127" first="1712" last="1722">
<title>Vascular endothelial cell growth-activated XBP1 splicing in endothelial cells is crucial for angiogenesis.</title>
<authorList>
<person name="Zeng L."/>
<person name="Xiao Q."/>
<person name="Chen M."/>
<person name="Margariti A."/>
<person name="Martin D."/>
<person name="Ivetic A."/>
<person name="Xu H."/>
<person name="Mason J."/>
<person name="Wang W."/>
<person name="Cockerill G."/>
<person name="Mori K."/>
<person name="Li J.Y."/>
<person name="Chien S."/>
<person name="Hu Y."/>
<person name="Xu Q."/>
</authorList>
<dbReference type="PubMed" id="23529610"/>
<dbReference type="DOI" id="10.1161/circulationaha.112.001337"/>
</citation>
<scope>FUNCTION (ISOFORMS 1 AND 2)</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INDUCTION (ISOFORM 2)</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2013" name="J. Biol. Chem." volume="288" first="859" last="872">
<title>XBP1 mRNA splicing triggers an autophagic response in endothelial cells through BECLIN-1 transcriptional activation.</title>
<authorList>
<person name="Margariti A."/>
<person name="Li H."/>
<person name="Chen T."/>
<person name="Martin D."/>
<person name="Vizcay-Barrena G."/>
<person name="Alam S."/>
<person name="Karamariti E."/>
<person name="Xiao Q."/>
<person name="Zampetaki A."/>
<person name="Zhang Z."/>
<person name="Wang W."/>
<person name="Jiang Z."/>
<person name="Gao C."/>
<person name="Ma B."/>
<person name="Chen Y.G."/>
<person name="Cockerill G."/>
<person name="Hu Y."/>
<person name="Xu Q."/>
<person name="Zeng L."/>
</authorList>
<dbReference type="PubMed" id="23184933"/>
<dbReference type="DOI" id="10.1074/jbc.m112.412783"/>
</citation>
<scope>FUNCTION (ISOFORM 2)</scope>
<scope>DNA-BINDING (ISOFORM 2)</scope>
<scope>INDUCTION (ISOFORM 2)</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-47 AND SER-68</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="27">
<citation type="journal article" date="2015" name="Cell. Signal." volume="27" first="82" last="89">
<title>XBP1 induces snail expression to promote epithelial-to-mesenchymal transition and invasion of breast cancer cells.</title>
<authorList>
<person name="Li H."/>
<person name="Chen X."/>
<person name="Gao Y."/>
<person name="Wu J."/>
<person name="Zeng F."/>
<person name="Song F."/>
</authorList>
<dbReference type="PubMed" id="25280941"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2014.09.018"/>
</citation>
<scope>FUNCTION (ISOFORM 2)</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2014" name="EMBO J." volume="33" first="2492" last="2506">
<title>Signal peptide peptidase functions in ERAD to cleave the unfolded protein response regulator XBP1u.</title>
<authorList>
<person name="Chen C.Y."/>
<person name="Malchus N.S."/>
<person name="Hehn B."/>
<person name="Stelzer W."/>
<person name="Avci D."/>
<person name="Langosch D."/>
<person name="Lemberg M.K."/>
</authorList>
<dbReference type="PubMed" id="25239945"/>
<dbReference type="DOI" id="10.15252/embj.201488208"/>
</citation>
<scope>FUNCTION (ISOFORMS 1 AND 2)</scope>
<scope>INTERACTION WITH DERL1; HM13; RNF139 AND XBP1 ISOFORM 2 (ISOFORM 1)</scope>
<scope>TOPOLOGY (ISOFORM 1)</scope>
<scope>PROTEOLYTIC CLEAVAGE (ISOFORM 1)</scope>
<scope>SUBCELLULAR LOCATION (ISOFORM 1 AND CYTOPLASMIC FORM)</scope>
<scope>UBIQUITINATION (ISOFORM 1 AND LUMINAL FORM)</scope>
<scope>STRESS-MEDIATED DOWN-REGULATION (ISOFORM 2)</scope>
<scope>MUTAGENESIS OF GLN-197; GLN-199; SER-200; SER-203; THR-212; CYS-215 AND ARG-232</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2014" name="J. Biol. Chem." volume="289" first="30625" last="30634">
<title>Unspliced X-box-binding protein 1 (XBP1) protects endothelial cells from oxidative stress through interaction with histone deacetylase 3.</title>
<authorList>
<person name="Martin D."/>
<person name="Li Y."/>
<person name="Yang J."/>
<person name="Wang G."/>
<person name="Margariti A."/>
<person name="Jiang Z."/>
<person name="Yu H."/>
<person name="Zampetaki A."/>
<person name="Hu Y."/>
<person name="Xu Q."/>
<person name="Zeng L."/>
</authorList>
<dbReference type="PubMed" id="25190803"/>
<dbReference type="DOI" id="10.1074/jbc.m114.571984"/>
</citation>
<scope>FUNCTION (ISOFORM 1)</scope>
<scope>DNA-BINDING (ISOFORMS 1 AND 2)</scope>
<scope>INTERACTION WITH HDAC3 AND AKT1 (ISOFORM 1)</scope>
<scope>SUBCELLULAR LOCATION (ISOFORM 1)</scope>
<scope>INDUCTION (ISOFORMS 1 AND 2)</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2006" name="Science" volume="314" first="268" last="274">
<title>The consensus coding sequences of human breast and colorectal cancers.</title>
<authorList>
<person name="Sjoeblom T."/>
<person name="Jones S."/>
<person name="Wood L.D."/>
<person name="Parsons D.W."/>
<person name="Lin J."/>
<person name="Barber T.D."/>
<person name="Mandelker D."/>
<person name="Leary R.J."/>
<person name="Ptak J."/>
<person name="Silliman N."/>
<person name="Szabo S."/>
<person name="Buckhaults P."/>
<person name="Farrell C."/>
<person name="Meeh P."/>
<person name="Markowitz S.D."/>
<person name="Willis J."/>
<person name="Dawson D."/>
<person name="Willson J.K.V."/>
<person name="Gazdar A.F."/>
<person name="Hartigan J."/>
<person name="Wu L."/>
<person name="Liu C."/>
<person name="Parmigiani G."/>
<person name="Park B.H."/>
<person name="Bachman K.E."/>
<person name="Papadopoulos N."/>
<person name="Vogelstein B."/>
<person name="Kinzler K.W."/>
<person name="Velculescu V.E."/>
</authorList>
<dbReference type="PubMed" id="16959974"/>
<dbReference type="DOI" id="10.1126/science.1133427"/>
</citation>
<scope>VARIANT [LARGE SCALE ANALYSIS] VAL-12</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2007" name="Breast Cancer Res." volume="9" first="R5" last="R5">
<title>Somatic sequence alterations in twenty-one genes selected by expression profile analysis of breast carcinomas.</title>
<authorList>
<person name="Chanock S.J."/>
<person name="Burdett L."/>
<person name="Yeager M."/>
<person name="Llaca V."/>
<person name="Langeroed A."/>
<person name="Presswalla S."/>
<person name="Kaaresen R."/>
<person name="Strausberg R.L."/>
<person name="Gerhard D.S."/>
<person name="Kristensen V."/>
<person name="Perou C.M."/>
<person name="Boerresen-Dale A.-L."/>
</authorList>
<dbReference type="PubMed" id="17224074"/>
<dbReference type="DOI" id="10.1186/bcr1637"/>
</citation>
<scope>VARIANT LYS-232</scope>
</reference>
<comment type="function">
<text evidence="2 6 18 28">Functions as a transcription factor during endoplasmic reticulum (ER) stress by regulating the unfolded protein response (UPR). Required for cardiac myogenesis and hepatogenesis during embryonic development, and the development of secretory tissues such as exocrine pancreas and salivary gland (By similarity). Involved in terminal differentiation of B lymphocytes to plasma cells and production of immunoglobulins (PubMed:11460154). Modulates the cellular response to ER stress in a PIK3R-dependent manner (PubMed:20348923). Binds to the cis-acting X box present in the promoter regions of major histocompatibility complex class II genes (PubMed:8349596). Involved in VEGF-induced endothelial cell (EC) proliferation and retinal blood vessel formation during embryonic development but also for angiogenesis in adult tissues under ischemic conditions. Functions also as a major regulator of the UPR in obesity-induced insulin resistance and type 2 diabetes for the management of obesity and diabetes prevention (By similarity).</text>
</comment>
<comment type="function">
<molecule>Isoform 1</molecule>
<text evidence="2 7 9 14 15 16 20 21 23 24 25 26 30">Plays a role in the unconventional cytoplasmic splicing processing of its own mRNA triggered by the endoplasmic reticulum (ER) transmembrane endoribonuclease ENR1: upon ER stress, the emerging XBP1 polypeptide chain, as part of a mRNA-ribosome-nascent chain (R-RNC) complex, cotranslationally recruits its own unprocessed mRNA through transient docking to the ER membrane and translational pausing, therefore facilitating efficient IRE1-mediated XBP1 mRNA isoform 2 production (PubMed:19394296, PubMed:21233347). In endothelial cells (EC), associated with KDR, promotes IRE1-mediated XBP1 mRNA isoform 2 productions in a vascular endothelial growth factor (VEGF)-dependent manner, leading to EC proliferation and angiogenesis (PubMed:23529610). Functions as a negative feed-back regulator of the potent transcription factor XBP1 isoform 2 protein levels through proteasome-mediated degradation, thus preventing the constitutive activation of the ER stress response signaling pathway (PubMed:16461360, PubMed:25239945). Inhibits the transactivation activity of XBP1 isoform 2 in myeloma cells (By similarity). Acts as a weak transcriptional factor (PubMed:8657566). Together with HDAC3, contributes to the activation of NFE2L2-mediated HMOX1 transcription factor gene expression in a PI(3)K/mTORC2/Akt-dependent signaling pathway leading to EC survival under disturbed flow/oxidative stress (PubMed:25190803). Binds to the ER stress response element (ERSE) upon ER stress (PubMed:11779464). Binds to the consensus 5'-GATGACGTG[TG]N(3)[AT]T-3' sequence related to cAMP responsive element (CRE)-like sequences (PubMed:8657566). Binds the Tax-responsive element (TRE) present in the long terminal repeat (LTR) of T-cell leukemia virus type 1 (HTLV-I) and to the TPA response elements (TRE) (PubMed:2321018, PubMed:2196176, PubMed:1903538, PubMed:8657566). Associates preferentially to the HDAC3 gene promoter region in a static flow-dependent manner (PubMed:25190803). Binds to the CDH5/VE-cadherin gene promoter region (PubMed:19416856).</text>
</comment>
<comment type="function">
<molecule>Isoform 2</molecule>
<text evidence="2 7 8 16 22 24 25 26 27">Functions as a stress-inducible potent transcriptional activator during endoplasmic reticulum (ER) stress by inducing unfolded protein response (UPR) target genes via binding to the UPR element (UPRE). Up-regulates target genes encoding ER chaperones and ER-associated degradation (ERAD) components to enhance the capacity of productive folding and degradation mechanism, respectively, in order to maintain the homeostasis of the ER under ER stress (PubMed:11779464, PubMed:25239945). Plays a role in the production of immunoglobulins and interleukin-6 in the presence of stimuli required for plasma cell differentiation (By similarity). Induces phospholipid biosynthesis and ER expansion (PubMed:15466483). Contributes to the VEGF-induced endothelial cell (EC) growth and proliferation in a Akt/GSK-dependent and/or -independent signaling pathway, respectively, leading to beta-catenin nuclear translocation and E2F2 gene expression (PubMed:23529610). Promotes umbilical vein EC apoptosis and atherosclerotisis development in a caspase-dependent signaling pathway, and contributes to VEGF-induced EC proliferation and angiogenesis in adult tissues under ischemic conditions (PubMed:19416856, PubMed:23529610). Involved in the regulation of endostatin-induced autophagy in EC through BECN1 transcriptional activation (PubMed:23184933). Plays a role as an oncogene by promoting tumor progression: stimulates zinc finger protein SNAI1 transcription to induce epithelial-to-mesenchymal (EMT) transition, cell migration and invasion of breast cancer cells (PubMed:25280941). Involved in adipocyte differentiation by regulating lipogenic gene expression during lactation. Plays a role in the survival of both dopaminergic neurons of the substantia nigra pars compacta (SNpc), by maintaining protein homeostasis and of myeloma cells. Increases insulin sensitivity in the liver as a response to a high carbohydrate diet, resulting in improved glucose tolerance. Improves also glucose homeostasis in an ER stress- and/or insulin-independent manner through both binding and proteasome-induced degradation of the transcription factor FOXO1, hence resulting in suppression of gluconeogenic genes expression and in a reduction of blood glucose levels. Controls the induction of de novo fatty acid synthesis in hepatocytes by regulating the expression of a subset of lipogenic genes in an ER stress- and UPR-independent manner (By similarity). Associates preferentially to the HDAC3 gene promoter region in a disturbed flow-dependent manner (PubMed:25190803). Binds to the BECN1 gene promoter region (PubMed:23184933). Binds to the CDH5/VE-cadherin gene promoter region (PubMed:19416856). Binds to the ER stress response element (ERSE) upon ER stress (PubMed:11779464). Binds to the 5'-CCACG-3' motif in the PPARG promoter (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="2 9 13 14 18 25 26">Isoform 2 interacts with SIRT1. Isoform 2 interacts with PIK3R1 and PIK3R2; the interactions are direct and induce translocation of XBP1 isoform 2 into the nucleus and the unfolded protein response (UPR) XBP1-dependent target genes activation in a ER stress- and/or insulin-dependent but PI3K-independent manner. Isoform 2 interacts with FOXO1; the interaction is direct and leads to FOXO1 ubiquitination and degradation via the proteasome pathway in hepatocytes (By similarity). Isoform 1 interacts with HM13 (PubMed:25239945). Isoform 1 interacts with RNF139; the interaction induces ubiquitination and degradation of isoform 1 (PubMed:25239945). Isoform 1 interacts (via luminal domain) with DERL1; the interaction obviates the need for ectodomain shedding prior HM13/SPP-mediated XBP1 isoform 1 cleavage (PubMed:25239945). Isoform 1 interacts with isoform 2; the interaction sequesters isoform 2 from the nucleus and enhances isoform 2 degradation in the cytoplasm (PubMed:16461360, PubMed:25239945). Isoform 1 interacts with HDAC3 and AKT1; the interactions occur in endothelial cell (EC) under disturbed flow (PubMed:25190803). Isoform 1 interacts with the oncoprotein FOS (PubMed:1903538). Isoform 2 interacts with ATF6; the interaction occurs in a ER stress-dependent manner and is required for DNA binding to the unfolded protein response element (UPRE) (PubMed:17765680). Isoform 2 interacts with PIK3R1; the interaction is direct and induces translocation of XBP1 isoform 2 into the nucleus and the unfolded protein response (UPR) XBP1-dependent target genes activation in a ER stress- and/or insulin-dependent but PI3K-independent manner (PubMed:20348923).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-6942961">
<id>P17861</id>
</interactant>
<interactant intactId="EBI-852157">
<id>P18850</id>
<label>ATF6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-6942961">
<id>P17861</id>
</interactant>
<interactant intactId="EBI-632965">
<id>Q9NS37</id>
<label>CREBZF</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-6942961">
<id>P17861</id>
</interactant>
<interactant intactId="EBI-447269">
<id>Q16665</id>
<label>HIF1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-6942961">
<id>P17861</id>
</interactant>
<interactant intactId="EBI-1050671">
<id>Q13404</id>
<label>UBE2V1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7631279">
<id>P17861-1</id>
</interactant>
<interactant intactId="EBI-347472">
<id>Q8TCT9</id>
<label>HM13</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="24">Endoplasmic reticulum</location>
</subcellularLocation>
<text evidence="24">Colocalizes with ERN1 and KDR in the endoplasmic reticulum in endothelial cells in a vascular endothelial growth factor (VEGF)-dependent manner (PubMed:23529610).</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 1</molecule>
<subcellularLocation>
<location evidence="9 15">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="9 15 18 25">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="26">Endoplasmic reticulum membrane</location>
<topology evidence="26">Single-pass type II membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="35">Endoplasmic reticulum membrane</location>
<topology evidence="35">Peripheral membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="15">Membrane</location>
<topology evidence="32">Peripheral membrane protein</topology>
</subcellularLocation>
<text evidence="2 9 15 25">Shows no preferential localization to either the nucleus or the cytoplasm (By similarity). Shuttles between the nucleus and the cytoplasm in a CRM1-dependent manner (PubMed:16461360). Localizes predominantly at the endoplasmic reticulum membrane as a membrane-spanning protein; whereas may be only marginally localized on the cytosolic side of the ER membrane as a peripheral membrane (PubMed:19394296, PubMed:25190803).</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 2</molecule>
<subcellularLocation>
<location evidence="9 15 18 19">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="2">Cytoplasm</location>
</subcellularLocation>
<text evidence="2">Localizes predominantly in the nucleus. Colocalizes in the nucleus with SIRT1. Translocates into the nucleus in a PIK3R-, ER stress-induced- and/or insulin-dependent manner (By similarity).</text>
</comment>
<comment type="subcellular location">
<molecule>X-box-binding protein 1, cytoplasmic form</molecule>
<subcellularLocation>
<location evidence="26">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="26">Nucleus</location>
</subcellularLocation>
<text evidence="26">Localizes in the cytoplasm and nucleus after HM13/SPP-mediated intramembranaire proteolytic cleavage of isoform 1 (PubMed:25239945).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P17861-1</id>
<name>1</name>
<name evidence="36">Unprocessed XBP-1</name>
<name evidence="31">XBP-1U</name>
<name evidence="32">XBP1u</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P17861-2</id>
<name>2</name>
<name evidence="36">Processed XBP-1</name>
<name evidence="31">XBP-1S</name>
<name evidence="32">XBP1s</name>
<sequence type="described" ref="VSP_012936"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="6 16 27">Expressed in plasma cells in rheumatoid synovium (PubMed:11460154). Over-expressed in primary breast cancer and metastatic breast cancer cells (PubMed:25280941). Isoform 1 and isoform 2 are expressed at higher level in proliferating as compared to confluent quiescent endothelial cells (PubMed:19416856).</text>
</comment>
<comment type="induction">
<text evidence="5 6 7 9 11 16 22 24 25 29">Isoform 1 is up-regulated at the recovery phase of the endoplasmic reticulum (ER) stress response and isoform 2 is up-regulated early during the ER stress response and gradually decreased at later phase of ER stress (PubMed:16461360). Isoform 1 and isoform 2 are down-regulated by laminar flow but up-regulated by disturbed flow in umbilical vein endothelial cells in vitro (at protein level) (PubMed:19416856). Down-regulated by the B-cell-specific transcription factor PAX5 (PubMed:8627152). Up-regulated by interleukin IL-6 in myeloma cells (PubMed:10375612). Up-regulated during plasma-cell differentiation, either through the CD40 receptor signaling pathway or mitogens such as lipopolysaccharide (LPS) (PubMed:11460154). Isoform 1 and isoform 2 are down-regulated by laminar flow but up-regulated by disturbed flow in umbilical vein endothelial cells in vitro (PubMed:25190803). Isoform 2 is up-regulated early during the ER stress response in a ATF6-dependent manner (PubMed:11779464, PubMed:17110785, PubMed:16461360). Isoform 2 is up-regulated by endostatin in a ERN1-dependent manner (PubMed:23184933). Isoform 2 is transiently up-regulated by the mitogenic vascular endothelial growth factor (VEGF) in endothelial cells (PubMed:23529610).</text>
</comment>
<comment type="domain">
<text evidence="2 7 9 15 20 30">Isoform 1 and isoform 2 N-terminus domains are necessary for nuclear localization targeting. Isoform 1 C-terminus domain confers localization to the cytoplasm and is sufficient to impose rapid degradation (By similarity). Isoform 1 transmembrane signal-anchor domain is necessary for its own mRNA to be recruited to the endoplasmic reticulum (ER) which will undergo unconventional ERN1-dependent splicing in response to ER stress (PubMed:19394296, PubMed:21233347). Isoform 1 N-terminus and C-terminus regions are necessary for DNA-binding and weak transcriptional activity, respectively. Isoform 2 N-terminus and C-terminus regions are necessary for DNA-binding and strong transcriptional activity upon ER stress, respectively (PubMed:11779464, PubMed:8657566). Isoform 2 C-terminus region contains a nuclear exclusion signal (NES) at positions 186 through 208. Isoform 2 C-terminus region contains a degradation domain at positions 209 through 261 (PubMed:16461360).</text>
</comment>
<comment type="PTM">
<molecule>Isoform 2</molecule>
<text evidence="19 37">Acetylated by EP300; acetylation positively regulates the transcriptional activity of XBP1 isoform 2 (PubMed:20955178). Isoform 2 is deacetylated by SIRT1; deacetylation negatively regulates the transcriptional activity of XBP1 isoform 2 (PubMed:20955178).</text>
</comment>
<comment type="PTM">
<molecule>Isoform 1</molecule>
<text evidence="2 7 9 26">Ubiquitinated, leading to proteasome-mediated degradation in response to ER stress (PubMed:11779464, PubMed:16461360, PubMed:25239945).</text>
</comment>
<comment type="PTM">
<text evidence="26">X-box-binding protein 1, cytoplasmic form and luminal form are produced by intramembrane proteolytic cleavage of ER membrane-anchored isoform 1 triggered by HM13/SPP in a DERL1-RNF139-dependent and VCP/p97-independent manner. X-box-binding protein 1, luminal form is ubiquitinated leading to proteasomal degradation (PubMed:25239945).</text>
</comment>
<comment type="disease">
<disease id="DI-02890">
<name>Major affective disorder 7</name>
<acronym>MAFD7</acronym>
<description>A major psychiatric disorder that is characterized by severe mood swings, with fluctuation between two abnormal mood states (manic or major depressive episode). Mania is accompanied by symptoms of euphoria, irritability, or excitation, whereas depression is associated with low mood and decreased motivation and energy.</description>
<dbReference type="MIM" id="612371"/>
</disease>
<text>Disease susceptibility may be associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform 2</molecule>
<text evidence="7 15 17">Potent transcriptional activator. Induced by unconventional ERN1-dependent splicing in response to endoplasmic reticulum stress (PubMed:11779464, PubMed:19622636, PubMed:19394296). ENR1 cleaves a 26-bp fragment causing a frameshift of the mRNA transcript (PubMed:11779464).</text>
</comment>
<comment type="similarity">
<text evidence="36">Belongs to the bZIP family.</text>
</comment>
<dbReference type="EMBL" id="M31627">
<property type="protein sequence ID" value="AAA36031.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X55543">
<property type="protein sequence ID" value="CAA39149.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L13850">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AB076383">
<property type="protein sequence ID" value="BAB82981.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB076384">
<property type="protein sequence ID" value="BAB82982.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CR456611">
<property type="protein sequence ID" value="CAG30497.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="Z93930">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC000938">
<property type="protein sequence ID" value="AAH00938.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC012841">
<property type="protein sequence ID" value="AAH12841.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC015709">
<property type="protein sequence ID" value="AAH15709.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS13847.1">
<molecule id="P17861-1"/>
</dbReference>
<dbReference type="PIR" id="A36299">
<property type="entry name" value="A36299"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001073007.1">
<molecule id="P17861-2"/>
<property type="nucleotide sequence ID" value="NM_001079539.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_005071.2">
<molecule id="P17861-1"/>
<property type="nucleotide sequence ID" value="NM_005080.3"/>
</dbReference>
<dbReference type="PDB" id="6R5Q">
<property type="method" value="EM"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="1=237-260"/>
</dbReference>
<dbReference type="PDB" id="6R6G">
<property type="method" value="EM"/>
<property type="resolution" value="3.70"/>
<property type="chains" value="1=237-260"/>
</dbReference>
<dbReference type="PDB" id="6R6P">
<property type="method" value="EM"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="1=237-260"/>
</dbReference>
<dbReference type="PDB" id="6R7Q">
<property type="method" value="EM"/>
<property type="resolution" value="3.90"/>
<property type="chains" value="1=237-260"/>
</dbReference>
<dbReference type="PDBsum" id="6R5Q"/>
<dbReference type="PDBsum" id="6R6G"/>
<dbReference type="PDBsum" id="6R6P"/>
<dbReference type="PDBsum" id="6R7Q"/>
<dbReference type="SMR" id="P17861"/>
<dbReference type="BioGRID" id="113331">
<property type="interactions" value="36"/>
</dbReference>
<dbReference type="DIP" id="DIP-41692N"/>
<dbReference type="IntAct" id="P17861">
<property type="interactions" value="16"/>
</dbReference>
<dbReference type="MINT" id="P17861"/>
<dbReference type="STRING" id="9606.ENSP00000216037"/>
<dbReference type="BindingDB" id="P17861"/>
<dbReference type="ChEMBL" id="CHEMBL1741176"/>
<dbReference type="iPTMnet" id="P17861"/>
<dbReference type="PhosphoSitePlus" id="P17861"/>
<dbReference type="BioMuta" id="XBP1"/>
<dbReference type="DMDM" id="60416406"/>
<dbReference type="EPD" id="P17861"/>
<dbReference type="jPOST" id="P17861"/>
<dbReference type="MassIVE" id="P17861"/>
<dbReference type="MaxQB" id="P17861"/>
<dbReference type="PaxDb" id="P17861"/>
<dbReference type="PeptideAtlas" id="P17861"/>
<dbReference type="PRIDE" id="P17861"/>
<dbReference type="ProteomicsDB" id="53522">
<molecule id="P17861-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="53523">
<molecule id="P17861-2"/>
</dbReference>
<dbReference type="Antibodypedia" id="10221">
<property type="antibodies" value="689 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="7494"/>
<dbReference type="Ensembl" id="ENST00000216037">
<molecule id="P17861-1"/>
<property type="protein sequence ID" value="ENSP00000216037"/>
<property type="gene ID" value="ENSG00000100219"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000344347">
<molecule id="P17861-2"/>
<property type="protein sequence ID" value="ENSP00000343155"/>
<property type="gene ID" value="ENSG00000100219"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000611155">
<molecule id="P17861-2"/>
<property type="protein sequence ID" value="ENSP00000481170"/>
<property type="gene ID" value="ENSG00000100219"/>
</dbReference>
<dbReference type="GeneID" id="7494"/>
<dbReference type="KEGG" id="hsa:7494"/>
<dbReference type="UCSC" id="uc062cvg.1">
<molecule id="P17861-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="7494"/>
<dbReference type="DisGeNET" id="7494"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000100219.16"/>
<dbReference type="GeneCards" id="XBP1"/>
<dbReference type="HGNC" id="HGNC:12801">
<property type="gene designation" value="XBP1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000100219">
<property type="expression patterns" value="Tissue enhanced (pancreas, salivary gland)"/>
</dbReference>
<dbReference type="MalaCards" id="XBP1"/>
<dbReference type="MIM" id="194355">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="612371">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P17861"/>
<dbReference type="OpenTargets" id="ENSG00000100219"/>
<dbReference type="PharmGKB" id="PA37400"/>
<dbReference type="eggNOG" id="KOG4005">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000017751"/>
<dbReference type="HOGENOM" id="CLU_069050_0_0_1"/>
<dbReference type="InParanoid" id="P17861"/>
<dbReference type="KO" id="K09027"/>
<dbReference type="OMA" id="KSCEQEC"/>
<dbReference type="OrthoDB" id="1269901at2759"/>
<dbReference type="PhylomeDB" id="P17861"/>
<dbReference type="TreeFam" id="TF319837"/>
<dbReference type="PathwayCommons" id="P17861"/>
<dbReference type="Reactome" id="R-HSA-381038">
<molecule id="P17861-2"/>
<property type="pathway name" value="XBP1(S) activates chaperone genes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-381070">
<molecule id="P17861-2"/>
<property type="pathway name" value="IRE1alpha activates chaperones"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-381183">
<molecule id="P17861-2"/>
<property type="pathway name" value="ATF6 (ATF6-alpha) activates chaperone genes"/>
</dbReference>
<dbReference type="SignaLink" id="P17861"/>
<dbReference type="SIGNOR" id="P17861"/>
<dbReference type="BioGRID-ORCS" id="7494">
<property type="hits" value="7 hits in 893 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="XBP1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="XBP1"/>
<dbReference type="GenomeRNAi" id="7494"/>
<dbReference type="Pharos" id="P17861">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:P17861"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 22"/>
</dbReference>
<dbReference type="RNAct" id="P17861">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000100219">
<property type="expression patterns" value="Expressed in body of pancreas and 142 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P17861">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005783">
<property type="term" value="C:endoplasmic reticulum"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030176">
<property type="term" value="C:integral component of endoplasmic reticulum membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="LIFEdb"/>
</dbReference>
<dbReference type="GO" id="GO:0031490">
<property type="term" value="F:chromatin DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000987">
<property type="term" value="F:cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0003700">
<property type="term" value="F:DNA-binding transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000981">
<property type="term" value="F:DNA-binding transcription factor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000255"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0030331">
<property type="term" value="F:estrogen receptor binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002020">
<property type="term" value="F:protease binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046982">
<property type="term" value="F:protein heterodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0019901">
<property type="term" value="F:protein kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000977">
<property type="term" value="F:RNA polymerase II transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990837">
<property type="term" value="F:sequence-specific double-stranded DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000976">
<property type="term" value="F:transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031625">
<property type="term" value="F:ubiquitin protein ligase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060612">
<property type="term" value="P:adipose tissue development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001525">
<property type="term" value="P:angiogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0036500">
<property type="term" value="P:ATF6-mediated unfolded protein response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006914">
<property type="term" value="P:autophagy"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0071230">
<property type="term" value="P:cellular response to amino acid stimulus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071498">
<property type="term" value="P:cellular response to fluid shear stress"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071332">
<property type="term" value="P:cellular response to fructose stimulus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042149">
<property type="term" value="P:cellular response to glucose starvation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071333">
<property type="term" value="P:cellular response to glucose stimulus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032869">
<property type="term" value="P:cellular response to insulin stimulus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071353">
<property type="term" value="P:cellular response to interleukin-4"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071499">
<property type="term" value="P:cellular response to laminar fluid shear stress"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990830">
<property type="term" value="P:cellular response to leukemia inhibitory factor"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071222">
<property type="term" value="P:cellular response to lipopolysaccharide"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031670">
<property type="term" value="P:cellular response to nutrient"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034599">
<property type="term" value="P:cellular response to oxidative stress"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071375">
<property type="term" value="P:cellular response to peptide hormone stimulus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035924">
<property type="term" value="P:cellular response to vascular endothelial growth factor stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035356">
<property type="term" value="P:cellular triglyceride homeostasis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042632">
<property type="term" value="P:cholesterol homeostasis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030968">
<property type="term" value="P:endoplasmic reticulum unfolded protein response"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001935">
<property type="term" value="P:endothelial cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060691">
<property type="term" value="P:epithelial cell maturation involved in salivary gland development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031017">
<property type="term" value="P:exocrine pancreas development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006633">
<property type="term" value="P:fatty acid biosynthetic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0055089">
<property type="term" value="P:fatty acid homeostasis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006955">
<property type="term" value="P:immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070059">
<property type="term" value="P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0036498">
<property type="term" value="P:IRE1-mediated unfolded protein response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001889">
<property type="term" value="P:liver development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007517">
<property type="term" value="P:muscle organ development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902236">
<property type="term" value="P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1900102">
<property type="term" value="P:negative regulation of endoplasmic reticulum unfolded protein response"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070373">
<property type="term" value="P:negative regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010832">
<property type="term" value="P:negative regulation of myotube differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060394">
<property type="term" value="P:negative regulation of pathway-restricted SMAD protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030512">
<property type="term" value="P:negative regulation of transforming growth factor beta receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0048666">
<property type="term" value="P:neuron development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006996">
<property type="term" value="P:organelle organization"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0014065">
<property type="term" value="P:phosphatidylinositol 3-kinase signaling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045766">
<property type="term" value="P:positive regulation of angiogenesis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010508">
<property type="term" value="P:positive regulation of autophagy"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045579">
<property type="term" value="P:positive regulation of B cell differentiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030335">
<property type="term" value="P:positive regulation of cell migration"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1900103">
<property type="term" value="P:positive regulation of endoplasmic reticulum unfolded protein response"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000353">
<property type="term" value="P:positive regulation of endothelial cell apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1903071">
<property type="term" value="P:positive regulation of ER-associated ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045600">
<property type="term" value="P:positive regulation of fat cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000347">
<property type="term" value="P:positive regulation of hepatocyte proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031062">
<property type="term" value="P:positive regulation of histone methylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002639">
<property type="term" value="P:positive regulation of immunoglobulin production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051024">
<property type="term" value="P:positive regulation of immunoglobulin secretion"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032755">
<property type="term" value="P:positive regulation of interleukin-6 production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1903489">
<property type="term" value="P:positive regulation of lactation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045348">
<property type="term" value="P:positive regulation of MHC class II biosynthetic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071073">
<property type="term" value="P:positive regulation of phospholipid biosynthetic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1900100">
<property type="term" value="P:positive regulation of plasma cell differentiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901985">
<property type="term" value="P:positive regulation of protein acetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042307">
<property type="term" value="P:positive regulation of protein import into nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051897">
<property type="term" value="P:positive regulation of protein kinase B signaling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001934">
<property type="term" value="P:positive regulation of protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045582">
<property type="term" value="P:positive regulation of T cell differentiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032008">
<property type="term" value="P:positive regulation of TOR signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1990440">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006990">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1904754">
<property type="term" value="P:positive regulation of vascular associated smooth muscle cell migration"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1904707">
<property type="term" value="P:positive regulation of vascular associated smooth muscle cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035470">
<property type="term" value="P:positive regulation of vascular wound healing"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031648">
<property type="term" value="P:protein destabilization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0015031">
<property type="term" value="P:protein transport"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0010506">
<property type="term" value="P:regulation of autophagy"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001558">
<property type="term" value="P:regulation of cell growth"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031647">
<property type="term" value="P:regulation of protein stability"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034976">
<property type="term" value="P:response to endoplasmic reticulum stress"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990418">
<property type="term" value="P:response to insulin-like growth factor stimulus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0055092">
<property type="term" value="P:sterol homeostasis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006366">
<property type="term" value="P:transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006511">
<property type="term" value="P:ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048010">
<property type="term" value="P:vascular endothelial growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="InterPro" id="IPR004827">
<property type="entry name" value="bZIP"/>
</dbReference>
<dbReference type="Pfam" id="PF07716">
<property type="entry name" value="bZIP_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00338">
<property type="entry name" value="BRLZ"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50217">
<property type="entry name" value="BZIP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00036">
<property type="entry name" value="BZIP_BASIC"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0037">Angiogenesis</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0072">Autophagy</keyword>
<keyword id="KW-0165">Cleavage on pair of basic residues</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0217">Developmental protein</keyword>
<keyword id="KW-0221">Differentiation</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0256">Endoplasmic reticulum</keyword>
<keyword id="KW-0444">Lipid biosynthesis</keyword>
<keyword id="KW-0443">Lipid metabolism</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0517">Myogenesis</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0553">Oncogene</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0653">Protein transport</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0735">Signal-anchor</keyword>
<keyword id="KW-0346">Stress response</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0813">Transport</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0834">Unfolded protein response</keyword>
<feature type="chain" description="X-box-binding protein 1" id="PRO_0000076543">
<location>
<begin position="1"/>
<end position="261"/>
</location>
</feature>
<feature type="chain" description="X-box-binding protein 1, cytoplasmic form" id="PRO_0000431891" evidence="35">
<location>
<begin position="1"/>
<end position="193"/>
</location>
</feature>
<feature type="chain" description="X-box-binding protein 1, luminal form" id="PRO_0000431892" evidence="35">
<location>
<begin position="196"/>
<end position="261"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="26">
<location>
<begin position="1"/>
<end position="185"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Signal-anchor for type II membrane protein" evidence="3 26 35">
<location>
<begin position="186"/>
<end position="203"/>
</location>
</feature>
<feature type="topological domain" description="Lumenal" evidence="26">
<location>
<begin position="204"/>
<end position="261"/>
</location>
</feature>
<feature type="domain" description="bZIP" evidence="4">
<location>
<begin position="70"/>
<end position="133"/>
</location>
</feature>
<feature type="region of interest" description="Basic motif" evidence="4">
<location>
<begin position="72"/>
<end position="94"/>
</location>
</feature>
<feature type="region of interest" description="Nuclear localization signal (NLS); in isoforms 1 and isoform 2" evidence="9">
<location>
<begin position="75"/>
<end position="92"/>
</location>
</feature>
<feature type="region of interest" description="Leucine-zipper" evidence="4">
<location>
<begin position="98"/>
<end position="133"/>
</location>
</feature>
<feature type="region of interest" description="Necessary for the translational pausing of its own mRNA" evidence="20">
<location>
<begin position="235"/>
<end position="261"/>
</location>
</feature>
<feature type="site" description="Cleavage; by HM13/SPP" evidence="35">
<location>
<begin position="194"/>
<end position="195"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="47"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="68"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_012936" evidence="31">
<original>LRLRAPLQQVQAQLSPLQNISPWILAVLTLQIQSLISCWAFWTTWTQSCSSNALPQSLPAWRSSQRSTQKDPVPYQPPFLCQWGRHQPSWKPLMN</original>
<variation>GAGPVVTPPEHLPMDSGGIDSSDSESDILLGILDNLDPVMFFKCPSPEPASLEELPEVYPEGPSSLPASLSLSVGTSSAKLEAINELIRFDHIYTKPLVLEIPSETESQANVVVKIEEAPLSPSENDHPEFIVSVKEEPVEDDLVPELGISNLLSSSHCPKPSSCLLDAYSDCGYGGSLSPFSDMSSLLGVNHSWEDTFANELFPQLISV</variation>
<location>
<begin position="167"/>
<end position="261"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast cancer sample; somatic mutation." id="VAR_035998" evidence="10">
<original>D</original>
<variation>V</variation>
<location>
<position position="12"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast cancer sample; somatic mutation; dbSNP:rs1379560430." id="VAR_033023" evidence="12">
<original>R</original>
<variation>K</variation>
<location>
<position position="232"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces endoplasmic reticulum localization of its own mRNA; when associated with E-193 and D-196." evidence="15">
<original>W</original>
<variation>E</variation>
<location>
<position position="189"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces endoplasmic reticulum localization of its own mRNA; when associated with E-189 and D-196." evidence="15">
<original>V</original>
<variation>E</variation>
<location>
<position position="193"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces endoplasmic reticulum localization of its own mRNA; when associated with D-198 and E-205." evidence="15">
<original>L</original>
<variation>E</variation>
<location>
<position position="194"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces endoplasmic reticulum localization of its own mRNA; when associated with E-189 and E-193." evidence="15">
<original>L</original>
<variation>D</variation>
<location>
<position position="196"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits HM13/SPP-mediated degradation of XBP1; when associated with L-199; L-200 and L-203." evidence="26">
<original>Q</original>
<variation>L</variation>
<location>
<position position="197"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces endoplasmic reticulum localization of its own mRNA; when associated with E-194 and E-205." evidence="15">
<original>I</original>
<variation>D</variation>
<location>
<position position="198"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits HM13/SPP-mediated degradation of XBP1; when associated with L-197; L-200 and L-203." evidence="26">
<original>Q</original>
<variation>L</variation>
<location>
<position position="199"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits HM13/SPP-mediated degradation of XBP1; when associated with L-197; L-199 and L-203." evidence="26">
<original>S</original>
<variation>L</variation>
<location>
<position position="200"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits HM13/SPP-mediated degradation of XBP1; when associated with L-197; L-199 and L-200." evidence="26">
<original>S</original>
<variation>L</variation>
<location>
<position position="203"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces endoplasmic reticulum localization of its own mRNA; when associated with E-194 and D-198." evidence="15">
<original>W</original>
<variation>E</variation>
<location>
<position position="205"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not induce glycosylation." evidence="26">
<original>T</original>
<variation>N</variation>
<location>
<position position="212"/>
</location>
</feature>
<feature type="mutagenesis site" description="Induces glycosylation." evidence="26">
<original>C</original>
<variation>N</variation>
<location>
<position position="215"/>
</location>
</feature>
<feature type="mutagenesis site" description="Induces glycosylation." evidence="26">
<original>R</original>
<variation>N</variation>
<location>
<position position="232"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces translational pausing, membrane targeting and cytoplasmic splicing of its own mRNA." evidence="20">
<original>L</original>
<variation>A</variation>
<location>
<position position="246"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases translational pausing of its own mRNA." evidence="20">
<original>S</original>
<variation>A</variation>
<location>
<position position="255"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces translational pausing, membrane targeting and cytoplasmic splicing of its own mRNA." evidence="20">
<original>W</original>
<variation>A</variation>
<location>
<position position="256"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA36031." ref="1" evidence="36">
<original>GQA</original>
<variation>AR</variation>
<location>
<begin position="33"/>
<end position="35"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; L13850." ref="3" evidence="36">
<original>N</original>
<variation>T</variation>
<location>
<position position="130"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; L13850." ref="3" evidence="36">
<original>L</original>
<variation>F</variation>
<location>
<position position="196"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O35426"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000255"/>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00978"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10375612"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11460154"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11779464"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15466483"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16461360"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16959974"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17110785"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17224074"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17765680"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1903538"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19394296"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19416856"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19622636"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20348923"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20955178"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21233347"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2196176"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23184933"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2321018"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23529610"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25190803"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25239945"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25280941"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8349596"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8627152"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8657566"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="11779464"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="19394296"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="2196176"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="2321018"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="25239945"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000305"/>
<evidence key="37" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="20955178"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:12801"/>
</source>
</evidence>
<sequence length="261" mass="28695" checksum="A4EF69EEE0D344A6" modified="2005-03-01" version="2">MVVVAAAPNPADGTPKVLLLSGQPASAAGAPAGQALPLMVPAQRGASPEAASGGLPQARKRQRLTHLSPEEKALRRKLKNRVAAQTARDRKKARMSELEQQVVDLEEENQKLLLENQLLREKTHGLVVENQELRQRLGMDALVAEEEAEAKGNEVRPVAGSAESAALRLRAPLQQVQAQLSPLQNISPWILAVLTLQIQSLISCWAFWTTWTQSCSSNALPQSLPAWRSSQRSTQKDPVPYQPPFLCQWGRHQPSWKPLMN</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

